SPINEWAY (ALSPW.PA) Fundamental Analysis & Valuation

EPA:ALSPW • FR001400N2P2

Current stock price

0.1546 EUR
-0.01 (-3.25%)
Last:

This ALSPW.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALSPW.PA Profitability Analysis

1.1 Basic Checks

  • ALSPW had negative earnings in the past year.
  • ALSPW had a positive operating cash flow in the past year.
  • In the past 5 years ALSPW always reported negative net income.
  • In the past 5 years ALSPW always reported negative operating cash flow.
ALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • ALSPW has a Return On Assets of -6.28%. This is in the lower half of the industry: ALSPW underperforms 67.74% of its industry peers.
  • Looking at the Return On Equity, with a value of -7.95%, ALSPW is doing worse than 66.13% of the companies in the same industry.
Industry RankSector Rank
ROA -6.28%
ROE -7.95%
ROIC N/A
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPW.PA Yearly ROA, ROE, ROICALSPW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 71.33%, ALSPW belongs to the top of the industry, outperforming 85.48% of the companies in the same industry.
  • ALSPW's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALSPW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
ALSPW.PA Yearly Profit, Operating, Gross MarginsALSPW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALSPW.PA Health Analysis

2.1 Basic Checks

  • ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALSPW has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALSPW has more shares outstanding
  • ALSPW has a better debt/assets ratio than last year.
ALSPW.PA Yearly Shares OutstandingALSPW.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALSPW.PA Yearly Total Debt VS Total AssetsALSPW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • ALSPW has an Altman-Z score of 1.39. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.
  • ALSPW has a Altman-Z score of 1.39. This is in the lower half of the industry: ALSPW underperforms 66.13% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that ALSPW is not too dependend on debt financing.
  • The Debt to Equity ratio of ALSPW (0.06) is better than 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACC6.9%
ALSPW.PA Yearly LT Debt VS Equity VS FCFALSPW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 3.19 indicates that ALSPW has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.19, ALSPW belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
  • A Quick Ratio of 2.04 indicates that ALSPW has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.04, ALSPW is doing good in the industry, outperforming 79.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.04
ALSPW.PA Yearly Current Assets VS Current LiabilitesALSPW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALSPW.PA Growth Analysis

3.1 Past

  • ALSPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.85%, which is quite impressive.
  • ALSPW shows a decrease in Revenue. In the last year, the revenue decreased by -5.46%.
  • Measured over the past years, ALSPW shows a quite strong growth in Revenue. The Revenue has been growing by 18.95% on average per year.
EPS 1Y (TTM)99.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.92%
Revenue 1Y (TTM)-5.46%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%-14.72%

3.2 Future

  • The Earnings Per Share is expected to decrease by -41.48% on average over the next years. This is quite bad
  • Based on estimates for the next years, ALSPW will show a very strong growth in Revenue. The Revenue will grow by 40.08% on average per year.
EPS Next Y-100.16%
EPS Next 2Y-41.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALSPW.PA Yearly Revenue VS EstimatesALSPW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALSPW.PA Yearly EPS VS EstimatesALSPW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 -5M -10M -15M -20M

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALSPW.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALSPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPW.PA Price Earnings VS Forward Price EarningsALSPW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALSPW is valued cheaply inside the industry as 98.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.79
ALSPW.PA Per share dataALSPW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • ALSPW's earnings are expected to decrease with -41.48% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.48%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALSPW.PA Dividend Analysis

5.1 Amount

  • ALSPW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALSPW.PA Fundamentals: All Metrics, Ratios and Statistics

SPINEWAY

EPA:ALSPW (3/26/2026, 7:00:00 PM)

0.1546

-0.01 (-3.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49M
Revenue(TTM)10.99M
Net Income(TTM)-1.90M
Analysts86.67
Price Target0.31 (100.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.5
P/FCF N/A
P/OCF 9.49
P/B 0.23
P/tB 0.38
EV/EBITDA 2.79
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.02
OCFY10.54%
SpS0.31
BVpS0.67
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.28%
ROE -7.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.33%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 1.36
Cap/Depr 118.46%
Cap/Sales 12.85%
Interest Coverage N/A
Cash Conversion 51.15%
Profit Quality N/A
Current Ratio 3.19
Quick Ratio 2.04
Altman-Z 1.39
F-Score6
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.92%
EPS Next Y-100.16%
EPS Next 2Y-41.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.46%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%-14.72%
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y97.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y120.98%
OCF growth 3YN/A
OCF growth 5YN/A

SPINEWAY / ALSPW.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SPINEWAY?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPW.PA.


Can you provide the valuation status for SPINEWAY?

ChartMill assigns a valuation rating of 1 / 10 to SPINEWAY (ALSPW.PA). This can be considered as Overvalued.


Can you provide the profitability details for SPINEWAY?

SPINEWAY (ALSPW.PA) has a profitability rating of 2 / 10.


What is the earnings growth outlook for SPINEWAY?

The Earnings per Share (EPS) of SPINEWAY (ALSPW.PA) is expected to decline by -100.16% in the next year.